It’s a big day for AveXis (NASDAQ:AVXS). The drug maker has reached an agreement to be acquired by Novartis (NASDAQ:NVS) for $8.
AveXis (NASDAQ:AVXS) investors are busy throwing a party today following the news that Novartis (NYSE:NVS) has reached an agreement to acquire AveXis for …
Chardan analyst Gbola Amusa is placing his confidence behind AveXis Inc (NASDAQ:AVXS) even in light of competitors Biogen Inc (NASDAQ:BIIB) and Ionis Pharmaceuticals …
Rarely in biotech do we see a situation where an investor can simply perform their own due diligence and be on the right …
Healthcare stocks Palatin Technologies (NYSEMKT:PTN), Novocure Ltd (NASDAQ:NVCR), and AveXis Inc (NASDAQ:AVXS) are reaping the benefits of clinical and corporate progress updates that have sent the …